Stock BANVT BANVIT BANDIRMA VITAMINLI YEM SANAYII ANONIM SIRKETI
Add to a list
To use this feature you must be a member
Log inSign up

Financials Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi

Equities

BANVT

TRABANVT92A9

Food Processing

Market Closed - Borsa Istanbul
Other stock markets
 11:09:24 2024-04-29 am EDT 		5-day change 1st Jan Change
193.6 TRY +5.45% Intraday chart for Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi +8.40% +116.31%
Feb. 27 Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,079 1,857 5,201 9,387 9,252 8,952
Enterprise Value (EV) 1 1,174 1,864 5,419 9,758 10,647 9,054
P/E ratio 13.3 x 16.8 x -26 x 98.7 x -20.9 x 9.4 x
Yield - - - - - -
Capitalization / Revenue 0.37 x 0.54 x 1.41 x 1.76 x 0.84 x 0.42 x
EV / Revenue 0.4 x 0.54 x 1.47 x 1.83 x 0.97 x 0.42 x
EV / EBITDA 3.59 x 4.72 x 41.9 x 18.6 x 31.2 x 4.32 x
EV / FCF -0.8 x -1.14 x -2.34 x -2.75 x -1.24 x -0.77 x
FCF Yield -125% -88% -42.7% -36.4% -80.9% -129%
Price to Book 1.48 x 1.7 x 5.18 x 7.55 x 4.32 x 2.03 x
Nbr of stocks (in thousands) 100,024 100,024 100,024 100,024 100,024 100,024
Reference price 2 10.79 18.57 52.00 93.85 92.50 89.50
Announcement Date 2/28/19 3/3/20 2/25/21 2/22/22 2/28/23 2/26/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 2,932 3,439 3,678 5,321 10,994 21,325
EBITDA 1 327.3 395.1 129.5 525.2 341.5 2,098
EBIT 1 185.3 220.8 -77.66 297.9 87.21 926.1
Operating Margin 6.32% 6.42% -2.11% 5.6% 0.79% 4.34%
Earnings before Tax (EBT) 1 94.18 140.9 -247.9 118.3 -461.5 1,409
Net income 1 81.07 110.6 -199.7 95.15 -442.7 952
Net margin 2.76% 3.21% -5.43% 1.79% -4.03% 4.46%
EPS 2 0.8100 1.105 -1.997 0.9513 -4.426 9.517
Free Cash Flow 1 -1,472 -1,640 -2,316 -3,552 -8,618 -11,711
FCF margin -50.21% -47.69% -62.98% -66.75% -78.39% -54.91%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/28/19 3/3/20 2/25/21 2/22/22 2/28/23 2/26/24
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 94.7 6.23 218 371 1,395 102
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 0.2895 x 0.0158 x 1.683 x 0.7057 x 4.084 x 0.0487 x
Free Cash Flow 1 -1,472 -1,640 -2,316 -3,552 -8,618 -11,711
ROE (net income / shareholders' equity) 12.1% 12.1% -19% 8.47% -26.1% 23.8%
ROA (Net income/ Total Assets) 8.03% 7.68% -2.06% 5.66% 1.01% 5%
Assets 1 1,010 1,440 9,705 1,682 -43,988 19,022
Book Value Per Share 2 7.310 10.90 10.00 12.40 21.40 44.00
Cash Flow per Share 2 1.700 2.950 5.300 7.690 5.370 12.60
Capex 1 1,633 1,893 2,192 3,577 8,650 14,417
Capex / Sales 55.71% 55.04% 59.61% 67.22% 78.68% 67.61%
Announcement Date 2/28/19 3/3/20 2/25/21 2/22/22 2/28/23 2/26/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. BANVT Stock
  4. Financials Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi